Intervention to Improve the Adherence in Community Pharmacies

Andalusian School of Public Health

Status: Unknown

Conditions: Diabetes Mellitus; Arterial Hypertension; Chronic Obstructive Pulmonary Disease (COPD

Treatments: Other: Placebo; Other: ANM

Study type: Interventional

Funder types: Other

Identifiers

NCT04195191

2018713122010

Details and patient eligibility

About

The ANM is the first initiative that puts advanced pharmaceutical care into practice in Andalusia (Spain). The aim of this is study is to evaluate the effectiveness of the intervention Assistance to New Medicines (ANM) in the improvement of adherence to treatment in community pharmacies.

Full description

Design: parallel cluster pragmatic randomized controlled trial. The study includes patients users of a community pharmacies, who meet the following inclusion criteria: patient who starts treatment of any of the following pathologies: Chronic Obstructive Pulmonary Disease (COPD), Arterial Hypertension or Diabetes Mellitus in Andalusia (Spain).

In order to avoid possible contamination between patients assigned to the control and intervention group, randomization will be carried out at the pharmacy level; preventing the pharmacist from applying part of the intervention to the control group.

Interventions: patients randomized: (i) current practice; or (ii) ANM intervention thru a pharmacist delivered support for a newly prescribed medicine.

Enrollment: 500 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria: patient who starts treatment of any of the following diseases:

• Chronic Obstructive Pulmonary Disease (COPD).
• Arterial Hypertension
• Diabetes Mellitus.
• Anticoagulants

Exclusion Criteria:

• those users who do not know how to read and write in Spanish,
• Suffer from a physical or mental disorder that makes it impossible to perform the

Trial design

Primary purpose: Health Services Research

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

500 participants in 2 patient groups, including a placebo group

Placebo

Placebo Comparator group

Description:

The usual practice by community pharmacies

Treatment:

Other: Placebo

ANM

Experimental group

Description:

This is an intervention based on pharmaceutical-patient communication through an open and fluid conversation, aimed at evaluating the patient's relationship with their new prescription, detecting possible problems, concerns and false beliefs or visual expectations.

Treatment:

Other: ANM